Now showing items 5481-5488 of 5488
The mystery of posttreatment cancer surveillance
(Wiley Periodicals, Inc., 2023-02-15)
Explaining behavioral health differences in urban and rural sexual minority adolescents
(Wiley Periodicals, Inc.GLSEN, 2023-01)
PurposeExperiences of sexuality-based discrimination (ie, minority stressors) against youth who identify as nonheterosexual (ie, sexual minority) have been associated with increased symptoms of anxiety, depression, and ...
The impact of community midwives on maternal healthcare utilization
(Wiley Periodicals, Inc.Advancing Partners & Communities, 2023-03)
Globally 800 women die every day from preventable causes related to pregnancy and childbirth. One of the major reasons for high maternal mortality ratios in many developing countries is the low proportion of births attended ...
The local health impacts of natural resource booms
(Wiley Periodicals, Inc.World Bank, 2023-02)
This paper uses novel micro-data on natural resources and administrative health data in Brazil to study how economic booms in minerals affect health at birth. By implementing a reduced-form estimation of shift-share research ...
Loss of oligodendrocyte ErbB receptor signaling leads to hypomyelination, reduced density of parvalbumin-expressing interneurons, and inhibitory function in the auditory cortex
(John Wiley & Sons, Inc., 2023-02)
For a long time, myelin was thought to be restricted to excitatory neurons, and studies on dysmyelination focused primarily on excitatory cells. Recent evidence showed that axons of inhibitory neurons in the neocortex are ...
Robust causal inference of drug-drug interactions
(John Wiley & Sons, Inc., 2023-03-30)
Body composition and mortality in men receiving prostate radiotherapy: A pooled analysis of NRG/RTOG 9406 and NRG/RTOG 0126
(Wiley Periodicals, Inc., 2023-03-01)
PurposeTo validate the association between body composition and mortality in men treated with radiation for localized prostate cancer (PCa). Secondarily, to integrate body composition as a factor to classify patients by ...
CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study
(Wiley Periodicals, Inc., 2023-03-01)
BackgroundCyclin E1 (CCNE1) is a potential predictive marker and therapeutic target in tubo-ovarian high-grade serous carcinoma (HGSC). Smaller studies have revealed unfavorable associations for CCNE1 amplification and ...